WEDNESDAY, April 29, 2015 – The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or ...
Subscribe to receive email notifications whenever new articles are published.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated May 8th, 2015), Cerner Multum™ (updated May 18th, 2015), Wolters Kluwer™ (updated May 6th, 2015) and others. To view content sources and attributions, please refer to our editorial policy.
We comply with the HONcode standard for trustworthy health information - verify here